{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:41:46Z","timestamp":1790743306280,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd008327","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,11,12]],"date-time":"2015-11-12T00:00:00Z","timestamp":1447286400000}}],"reference-count":125,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008327.pub2","type":"journal-article","created":{"date-parts":[[2015,11,12]],"date-time":"2015-11-12T03:41:08Z","timestamp":1447299668000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Interventions for metabolic bone disease in children with chronic kidney disease"],"prefix":"10.1002","volume":"2015","author":[{"given":"Deirdre","family":"Hahn","sequence":"first","affiliation":[{"name":"The Children's Hospital at Westmead; Department of Nephrology; Locked Bag 4001 Westmead NSW Australia 2145"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth M","family":"Hodson","sequence":"additional","affiliation":[{"name":"The Children's Hospital at Westmead; Cochrane Kidney and Transplant, Centre for Kidney Research; Locked Bag 4001 Westmead NSW Australia 2145"},{"name":"The University of Sydney; Sydney School of Public Health; Sydney NSW Australia 2006"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C","family":"Craig","sequence":"additional","affiliation":[{"name":"The Children's Hospital at Westmead; Cochrane Kidney and Transplant, Centre for Kidney Research; Locked Bag 4001 Westmead NSW Australia 2145"},{"name":"The University of Sydney; Sydney School of Public Health; Sydney NSW Australia 2006"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,11,12]]},"reference":[{"issue":"7","key":"10.1002\/14651858.CD008327.pub2-BIB0002|cit1","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1007\/s004670000365","article-title":"Calcitriol pulse therapy is not more effective than daily calcitriol therapy in controlling secondary hyperparathyroidism in children with chronic renal failure. European Study Group on Vitamin D in Children with Renal Failure","volume":"14","author":"Ardissino","year":"2000","journal-title":"Pediatric Nephrology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD008327.pub2-BIB0001|cit2","first-page":"562A","article-title":"Growth and PTH in children treated with daily vs intermittent oral calcitriol for secondary hyperparathyroidism. Preliminary results [abstract]","volume":"9","author":"Ardissino","year":"1998","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD008327.pub2-BIB0003|cit3","first-page":"581","article-title":"Effect of 1a-hydroxycholecalciferol on glomerular filtration rate in children with moderate renal failure [abstract]","volume":"22","author":"Eke","year":"1982","journal-title":"Kidney International"},{"issue":"10","key":"10.1002\/14651858.CD008327.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/adc.58.10.810","article-title":"Effect of low dose 1 alpha-hydroxycholecalciferol on glomerular filtration rate in moderate renal failure","volume":"58","author":"Eke","year":"1983","journal-title":"Archives of Disease in Childhood"},{"issue":"2","key":"10.1002\/14651858.CD008327.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/S0022-3476(05)82925-7","article-title":"Linear growth and anthropometric and nutritional measurements in children with mild to moderate renal insufficiency: a report of the Growth Failure in Children with Renal Diseases Study","volume":"116","author":"Abitbol","year":"1990","journal-title":"Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD008327.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0022-3476(05)82914-2","article-title":"Growth failure in children with renal diseases. A clinical trial in pediatric nephrology: Growth Failure in Renal Diseases (GFRD) Study","volume":"116","author":"Anonymous","year":"1990","journal-title":"Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD008327.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/BF00864403","article-title":"Masking of physicians in the Growth Failure in Children with Renal Diseases Clinical Trial","volume":"7","author":"Boyle","year":"1993","journal-title":"Pediatric Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD008327.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/S0022-3476(05)82921-X","article-title":"Data coordination and management in the Growth Failure in Children with Renal Diseases Study","volume":"116","author":"Boyle","year":"1990","journal-title":"Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD008327.pub2-BIB0009|cit9","first-page":"S1","article-title":"Final report of the Growth Failure in Children with Renal Diseases Study","volume":"129","author":"Brouhard","year":"1996","journal-title":"Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD008327.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/S0022-3476(05)82920-8","article-title":"Descriptions of the participating centers and patient population in the Growth Failure in Children with Renal Diseases Study","volume":"116","author":"Chan","year":"1990","journal-title":"Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD008327.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0022-3476(05)82917-8","article-title":"Rationale of the Growth Failure in Children with Renal Diseases Study","volume":"116","author":"Chan","year":"1990","journal-title":"Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD008327.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0022-3476(05)82915-4","article-title":"History and organization of the Growth Failure in Children with Renal Diseases Study","volume":"116","author":"Chan","year":"1990","journal-title":"Journal of Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD008327.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0022-3476(05)83128-2","article-title":"A prospective, double-blind study of growth failure in children with chronic renal insufficiency and the effectiveness of treatment with calcitriol versus dihydrotachysterol. The Growth Failure in Children with Renal Diseases Investigators","volume":"124","author":"Chan","year":"1994","journal-title":"Journal of Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD008327.pub2-BIB0014|cit14","first-page":"280","article-title":"Growth failure renal diseases (GFRD) study: calcitriol (1, 25-d) vs dihydrotachysterol (DHT) [abstract no: 11P]","volume":"3","author":"Chan","year":"1992","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD008327.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/S0022-3476(05)82918-X","article-title":"Protocol of the Growth Failure in Children with Renal Diseases Study","volume":"116","author":"Chan","year":"1990","journal-title":"Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD008327.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/S0022-3476(05)82922-1","article-title":"Statistical methods and determination of sample size in the Growth Failure in Children with Renal Diseases Study","volume":"116","author":"Chinchilli","year":"1990","journal-title":"Journal of Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD008327.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1080\/07315724.1996.10718633","article-title":"Nutritional intake in children with renal insufficiency: a report of the Growth Failure in Children with Renal Diseases Study","volume":"15","author":"Foreman","year":"1996","journal-title":"Journal of the American College of Nutrition"},{"issue":"2","key":"10.1002\/14651858.CD008327.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/S0022-3476(05)82926-9","article-title":"Serum osteocalcin concentrations in children with chronic renal insufficiency who are not undergoing dialysis. Growth Failure in Children with Renal Diseases Study","volume":"116","author":"Friedman","year":"1990","journal-title":"Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD008327.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/S0022-3476(05)82916-6","article-title":"Growth Failure in Children with Renal Diseases Study: an overview from the National Institutes of Health and the Advisory Committee","volume":"116","author":"Hirschman","year":"1990","journal-title":"Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD008327.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/S0022-3476(05)82924-5","article-title":"Quality control of the nutritional component of the Growth Failure in Children with Renal Diseases Study","volume":"116","author":"Massie","year":"1990","journal-title":"Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD008327.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/S0022-3476(05)82923-3","article-title":"Laboratory quality control for a multicenter clinical trial: a report from the Growth Failure in Children with Renal Diseases Study","volume":"116","author":"Mendoza","year":"1990","journal-title":"Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD008327.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/S0022-3476(05)82919-1","article-title":"Masking procedure, randomization and stratification, and compliance monitoring in the Growth Failure in Children with Renal Diseases Study","volume":"116","author":"Shasky","year":"1990","journal-title":"Journal of Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD008327.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1681\/ASN.V61126","article-title":"The relationship between calcium, phosphorus, and sodium intake, race, and blood pressure in children with renal insufficiency: a report of the Growth Failure in Children with Renal Diseases (GFRD) Study","volume":"6","author":"Trachtman","year":"1995","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD008327.pub2-BIB0024|cit24","first-page":"259","article-title":"Dietary calcium (C) and phosphorus (P) intake, nutritional status, and blood pressure (BP) in black vs. white children: report of GFRD clinical trial [abstract]","volume":"4","author":"Trachtman","year":"1993","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD008327.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s00467-004-1792-6","article-title":"Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis","volume":"20","author":"Greenbaum","year":"2005","journal-title":"Pediatric Nephrology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD008327.pub2-BIB0026|cit26","first-page":"771A","article-title":"IV calcitriol safely and effectively reduces iPTH levels in pediatric patients [abstract no: A4031]","volume":"12","author":"Salusky","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD008327.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1053\/j.ajkd.2007.03.008","article-title":"Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis","volume":"49","author":"Greenbaum","year":"2007","journal-title":"American Journal of Kidney Diseases"},{"issue":"Nov","key":"10.1002\/14651858.CD008327.pub2-BIB0028|cit28","first-page":"199A","article-title":"Paricalcitol (Zemplar\u00ae) injection for the treatment of secondary hyperparathyroidism in pediatric hemodialysis patients [abstract]","volume":"14","author":"Kommala","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD008327.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s11255-009-9688-9","article-title":"Short-term efficacy of sevelamer versus calcium acetate in patients with chronic kidney disease stage 3-4","volume":"42","author":"Gulati","year":"2010","journal-title":"International Urology & Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD008327.pub2-BIB0030|cit30","first-page":"192","article-title":"Treatment of childhood renal osteodystrophy with calcitriol or ergocalciferol","volume":"24","author":"Hodson","year":"1985","journal-title":"Clinical Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD008327.pub2-BIB0031|cit31","first-page":"44","article-title":"Comparisons between oral and intraperitoneal 1,25-dihydroxyvitamin D3 therapy in children treated with peritoneal dialysis","volume":"42","author":"Jones","year":"1994","journal-title":"Clinical Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD008327.pub2-BIB0032|cit32","first-page":"C75","article-title":"Comparison of intermittent and continuous (daily) oral calcitriol for treatment of renal hyperparathyroidism in children on dialysis [abstract]","volume":"9","author":"Klaus","year":"1995","journal-title":"Pediatric Nephrology"},{"issue":"6496","key":"10.1002\/14651858.CD008327.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/bmj.291.6496.623","article-title":"Suppression of secondary hyperparathyroidism in children with chronic renal failure by high dose phosphate binders: calcium carbonate versus aluminium hydroxide","volume":"291","author":"Mak","year":"1985","journal-title":"British Medical Journal Clinical Research Ed"},{"issue":"4","key":"10.1002\/14651858.CD008327.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1053\/j.ajkd.2005.12.039","article-title":"A randomized crossover trial comparing sevelamer with calcium acetate in children with CKD","volume":"47","author":"Pieper","year":"2006","journal-title":"American Journal of Kidney Diseases"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD008327.pub2-BIB0035|cit35","first-page":"681","article-title":"Sevelamer vs. calcium acetate in children with chronic renal failure [abstract]","volume":"18","author":"Pieper","year":"2003","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"8","key":"10.1002\/14651858.CD008327.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s00467-013-2431-x","article-title":"Ergocalciferol decreases erythropoietin resistance in children with chronic kidney disease stage 5","volume":"28","author":"Rianthavorn","year":"2013","journal-title":"Pediatric Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD008327.pub2-BIB0037|cit37","first-page":"328","article-title":"Prospective assessment of aluminum retention in dialyzed patients given calcium carbonate or aluminum hydroxide [abstract]","volume":"37","author":"Goodman","year":"1990","journal-title":"Kidney International"},{"issue":"1","key":"10.1002\/14651858.CD008327.pub2-BIB0038|cit38","first-page":"451","article-title":"Prospective trial of calcium carbonate versus aluminum hydroxide with oral calcitriol therapy in renal osteodystrophy [abstract]","volume":"37","author":"Salusky","year":"1990","journal-title":"Kidney International"},{"key":"10.1002\/14651858.CD008327.pub2-BIB0039|cit39","unstructured":"Salusky IB Foley J Goodman WG Calcium carbonate versus aluminum hydroxide with oral calcitriol therapy in pediatric renal osteodystrophy. [abstract] 11th International Congress of Nephrology; 1990 Jul 15-20; Tokyo, Japan 1990 416A"},{"issue":"8","key":"10.1002\/14651858.CD008327.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1056\/NEJM199102213240804","article-title":"Aluminum accumulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease","volume":"324","author":"Salusky","year":"1991","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD008327.pub2-BIB0041|cit41","first-page":"850","article-title":"Skeletal response to intermittent oral or intraperitoneal calcitriol in patients with secondary hyperparathyroidism [abstract]","volume":"5","author":"Goodman","year":"1994","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD008327.pub2-BIB0042|cit42","first-page":"672","article-title":"Skeletal response to one year of intermittent calcitriol therapy in dialyzed children [abstract no: 23P]","volume":"3","author":"Goodman","year":"1992","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD008327.pub2-BIB0043|cit43","first-page":"531","article-title":"A prospective evaluation of the peritonitis rates between oral & intraperitoneal calcitriol [abstract]","volume":"6","author":"Greenbaum","year":"1995","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD008327.pub2-BIB0044|cit44","first-page":"412","article-title":"Peritonitis rates in children on CCPD treated with intermittent calcitriol therapy: oral vs intraperitoneal [abstract]","volume":"3","author":"Holloway","year":"1992","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD008327.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1046\/j.1523-1755.1998.00724.x","article-title":"Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD","volume":"53","author":"Kuizon","year":"1998","journal-title":"Kidney International"},{"issue":"3","key":"10.1002\/14651858.CD008327.pub2-BIB0046|cit46","first-page":"676","article-title":"Intermittent oral vs intraperitoneal calcitriol therapy in children on CCPD [abstract]","volume":"3","author":"Ramirez","year":"1992","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD008327.pub2-BIB0047|cit47","first-page":"C45","article-title":"Pulse calcitriol therapy: a prospective randomized trial [abstract no: FC037]","volume":"9","author":"Salusky","year":"1995","journal-title":"Pediatric Nephrology"},{"key":"10.1002\/14651858.CD008327.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"S441","DOI":"10.1177\/089686089901902S72","article-title":"Consequences of intermittent calcitriol therapy in pediatric patients with secondary hyperparathyroidism","volume":"19 Suppl 2","author":"Salusky","year":"1999","journal-title":"Peritoneal Dialysis International"},{"issue":"7","key":"10.1002\/14651858.CD008327.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s004670000352","article-title":"Implications of intermittent calcitriol therapy on growth and secondary hyperparathyroidism","volume":"14","author":"Salusky","year":"2000","journal-title":"Pediatric Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD008327.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1046\/j.1523-1755.1998.00045.x","article-title":"Intermittent calcitriol therapy in secondary hyperparathyroidism: a comparison between oral and intraperitoneal administration","volume":"54","author":"Salusky","year":"1998","journal-title":"Kidney International"},{"issue":"5","key":"10.1002\/14651858.CD008327.pub2-BIB0051|cit51","first-page":"C68","article-title":"Present strategies for the management of renal osteodystrophy [abstract no: S-15.3]","volume":"6","author":"Salusky","year":"1992","journal-title":"Pediatric Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD008327.pub2-BIB0052|cit52","first-page":"855","article-title":"Pulse calcitriol therapy: a prospective randomized trial [abstract]","volume":"5","author":"Salusky","year":"1994","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD008327.pub2-BIB0053|cit53","first-page":"47A","article-title":"Skeletal response to phosphate binders and intermittent oral vitamin D in dialyzed children with secondary hyperparathyroidism [abstract no: F-FC044]","volume":"16","author":"Hernandez","year":"2005","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Abstracts","key":"10.1002\/14651858.CD008327.pub2-BIB0054|cit54","first-page":"134A","article-title":"Differential effect of doxercalciferol and calcitriol on skeletal lesions of secondary hyperparathyroidism [abstract no: TH-PO133]","volume":"17","author":"Pereira","year":"2006","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD008327.pub2-BIB0055|cit55","first-page":"202A","article-title":"Skeletal response to the treatment of secondary hyperparathyroidism: a comparison between calcitriol and 1-Alpha-D2 [abstract no: F-PO643]","volume":"14","author":"Salusky","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD008327.pub2-BIB0056|cit56","first-page":"281A","article-title":"Prospective comparison of calcium-based binder versus sevelamer HCL on the control of the skeletal lesions of secondary hyperparathyroidism [abstract no: F-PO989]","volume":"15","author":"Salusky","year":"2004","journal-title":"Journal of the American Society of Nephrology"},{"issue":"8","key":"10.1002\/14651858.CD008327.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1681\/ASN.2004100885","article-title":"Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols","volume":"16","author":"Salusky","year":"2005","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD008327.pub2-BIB0058|cit58","first-page":"206A","article-title":"A prospective assessment of sevelamer hydrochloride versus calcium carbonate in dialyzed children. [abstract no: F-PO661]","volume":"14","author":"Salusky","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD008327.pub2-BIB0059|cit59","first-page":"739A","article-title":"Comparison between first and second generation PTH assays as predictors of bone turnover during treatment of secondary hyperparathyroidism in dialyzed children [abstract no: SA-PO833]","volume":"16","author":"Salusky","year":"2005","journal-title":"Journal of the American Society of Nephrology"},{"issue":"7","key":"10.1002\/14651858.CD008327.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00467-009-1143-8","article-title":"Response of different PTH assays to therapy with sevelamer or CaCO3 and active vitamin D sterols","volume":"24","author":"Wesseling-Perry","year":"2009","journal-title":"Pediatric Nephrology"},{"issue":"Oct","key":"10.1002\/14651858.CD008327.pub2-BIB0061|cit61","first-page":"279A","article-title":"Similar predictive value of bone turnover by first and second generation PTH assays during treatment of secondary hyperparthyroidism in dialyzed children [abstract no: F-PO980]","volume":"15","author":"Wesseling-Perry","year":"2004","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Abstracts","key":"10.1002\/14651858.CD008327.pub2-BIB0062|cit62","first-page":"134A","article-title":"Effects of vitamin D on FGF-23, PTH and the skeletal lesions of secondary hyperparathyroidism [abstract no: TH-PO132]","volume":"17","author":"Wesseling-Perry","year":"2006","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD008327.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/ki.2010.352","article-title":"Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism","volume":"79","author":"Wesseling-Perry","year":"2011","journal-title":"Kidney International"},{"issue":"Abstracts","key":"10.1002\/14651858.CD008327.pub2-BIB0064|cit64","first-page":"134A","article-title":"Differential effect of doxercalciferol and calcitriol on skeletal lesions of secondary hyperparathyroidism [abstract no: TH-PO133]","volume":"17","author":"Pereira","year":"2006","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD008327.pub2-BIB0065|cit65","first-page":"202A","article-title":"Skeletal response to the treatment of secondary hyperparathyroidism: a comparison between calcitriol and 1-Alpha-D2 [abstract no: F-PO643]","volume":"14","author":"Salusky","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD008327.pub2-BIB0066|cit66","first-page":"739A","article-title":"Comparison between first and second generation PTH assays as predictors of bone turnover during treatment of secondary hyperparathyroidism in dialyzed children [abstract no: SA-PO833]","volume":"16","author":"Salusky","year":"2005","journal-title":"Journal of the American Society of Nephrology"},{"issue":"7","key":"10.1002\/14651858.CD008327.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00467-009-1143-8","article-title":"Response of different PTH assays to therapy with sevelamer or CaCO3 and active vitamin D sterols","volume":"24","author":"Wesseling-Perry","year":"2009","journal-title":"Pediatric Nephrology"},{"issue":"Oct","key":"10.1002\/14651858.CD008327.pub2-BIB0068|cit68","first-page":"279A","article-title":"Similar predictive value of bone turnover by first and second generation PTH assays during treatment of secondary hyperparthyroidism in dialyzed children [abstract no: F-PO980]","volume":"15","author":"Wesseling-Perry","year":"2004","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Abstracts","key":"10.1002\/14651858.CD008327.pub2-BIB0069|cit69","first-page":"134A","article-title":"Effects of vitamin D on FGF-23, PTH and the skeletal lesions of secondary hyperparathyroidism [abstract no: TH-PO132]","volume":"17","author":"Wesseling-Perry","year":"2006","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD008327.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/ki.2010.352","article-title":"Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism","volume":"79","author":"Wesseling-Perry","year":"2011","journal-title":"Kidney International"},{"issue":"Abstracts","key":"10.1002\/14651858.CD008327.pub2-BIB0071|cit71","first-page":"134A","article-title":"Differential effect of doxercalciferol and calcitriol on skeletal lesions of secondary hyperparathyroidism [abstract no: TH-PO133]","volume":"17","author":"Pereira","year":"2006","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD008327.pub2-BIB0072|cit72","first-page":"202A","article-title":"Skeletal response to the treatment of secondary hyperparathyroidism: a comparison between calcitriol and 1-Alpha-D2 [abstract no: F-PO643]","volume":"14","author":"Salusky","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD008327.pub2-BIB0073|cit73","first-page":"739A","article-title":"Comparison between first and second generation PTH assays as predictors of bone turnover during treatment of secondary hyperparathyroidism in dialyzed children [abstract no: SA-PO833]","volume":"16","author":"Salusky","year":"2005","journal-title":"Journal of the American Society of Nephrology"},{"issue":"7","key":"10.1002\/14651858.CD008327.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00467-009-1143-8","article-title":"Response of different PTH assays to therapy with sevelamer or CaCO3 and active vitamin D sterols","volume":"24","author":"Wesseling-Perry","year":"2009","journal-title":"Pediatric Nephrology"},{"issue":"Oct","key":"10.1002\/14651858.CD008327.pub2-BIB0075|cit75","first-page":"279A","article-title":"Similar predictive value of bone turnover by first and second generation PTH assays during treatment of secondary hyperparthyroidism in dialyzed children [abstract no: F-PO980]","volume":"15","author":"Wesseling-Perry","year":"2004","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Abstracts","key":"10.1002\/14651858.CD008327.pub2-BIB0076|cit76","first-page":"134A","article-title":"Effects of vitamin D on FGF-23, PTH and the skeletal lesions of secondary hyperparathyroidism [abstract no: TH-PO132]","volume":"17","author":"Wesseling-Perry","year":"2006","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD008327.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/ki.2010.352","article-title":"Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism","volume":"79","author":"Wesseling-Perry","year":"2011","journal-title":"Kidney International"},{"issue":"5","key":"10.1002\/14651858.CD008327.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s00467-003-1091-7","article-title":"Growth in children with chronic renal failure on intermittent versus daily calcitriol","volume":"18","author":"Schmitt","year":"2003","journal-title":"Pediatric Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD008327.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2215\/CJN.04760511","article-title":"Ergocalciferol supplementation in children with CKD delays the onset of secondary hyperparathyroidism: a randomized trial","volume":"7","author":"Shroff","year":"2012","journal-title":"Clinical Journal of The American Society of Nephrology: CJASN"},{"issue":"9","key":"10.1002\/14651858.CD008327.pub2-BIB0080|cit80","first-page":"1634","article-title":"Ergocalciferol supplementation in children with CKD delays the onset of secondary hyperparathyroidism-a randomised, double-blinded placebo controlled study [abstract no: PS1-THU-506]","volume":"26","author":"Shroff","year":"2011","journal-title":"Pediatric Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD008327.pub2-BIB0081|cit81","first-page":"C38","article-title":"The prevention of renal osteodystrophy (ROD) in children under going CAPD: a prospective randomised trial using 1 a hydroxycholecalciferol (1a) [abstract]","volume":"1","author":"Watson","year":"1987","journal-title":"Pediatric Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD008327.pub2-BIB0082|cit82","first-page":"220","article-title":"Renal osteodystrophy in children on CAPD: a prospective trial of 1-alpha-hydroxycholecalciferol therapy","volume":"9","author":"Watson","year":"1988","journal-title":"Child Nephrology & Urology"},{"issue":"3","key":"10.1002\/14651858.CD008327.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1046\/j.1523-1755.2000.00255.x","article-title":"No difference in intestinal strontium absorption after oral or IV calcitriol in children with secondary hyperparathyroidism. The European Study Group on Vitamin D in Children with Renal Failure","volume":"58","author":"Ardissino","year":"2000","journal-title":"Kidney International"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD008327.pub2-BIB0084|cit84","first-page":"571A","article-title":"Equal intestinal calcium absorption and greater PTH suppression with oral vs IV calcitriol bolus in children with secondary hyperparathyroidism [abstract]","volume":"8","author":"Ardissino","year":"1997","journal-title":"Journal of the American Society of Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD008327.pub2-BIB0085|cit85","first-page":"1810","article-title":"Oral and IV calcitriol pulse are equally effective on control of serum PTH and in stimulating intestinal calcium absorption [abstract no: A2821]","volume":"7","author":"Ardissino","year":"1996","journal-title":"Journal of the American Society of Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD008327.pub2-BIB0086|cit86","first-page":"A115","article-title":"Higher intestinal calcium absorption with iv calcitriol compared to oral in children with 2\u00ba hyperparathyroidism (HPT) [abstract]","volume":"12","author":"Schmitt","year":"1997","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD008327.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1203\/00006450-198601000-00002","article-title":"Effects of 1,25-dihydroxyvitamin-D3 treatment on mineral balance in children with end stage renal disease undergoing chronic hemofiltration","volume":"20","author":"Bettinelli","year":"1986","journal-title":"Pediatric Research"},{"issue":"6","key":"10.1002\/14651858.CD008327.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00467-013-2720-4","article-title":"Calcium and vitamin D for osteoprotection in children with new-onset nephrotic syndrome treated with steroids: a prospective, randomized, controlled, interventional study","volume":"29","author":"Choudhary","year":"2014","journal-title":"Pediatric Nephrology"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD008327.pub2-BIB0089|cit89","first-page":"544","article-title":"Treatment of bone loss in renal transplant children and adolescents [abstract]","volume":"18","author":"Husseini","year":"2003","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD008327.pub2-BIB0090|cit90","unstructured":"El Husseini A Elagroudy A Elsayed M Sobh M Ghoneim M Treatment of bone loss with vitamin D in live related kidney transplant children and adolescents: a prospective randomized study 41st Congress of ERA-EDTA; 2004 May 15-18; Lisbon (Portugal) 2004 93"},{"issue":"4","key":"10.1002\/14651858.CD008327.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1399-3046.2004.00191.x","article-title":"Treatment of osteopenia and osteoporosis in renal transplant children and adolescents","volume":"8","author":"Husseini","year":"2004","journal-title":"Pediatric Transplantation"},{"issue":"12","key":"10.1002\/14651858.CD008327.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1111\/j.1600-6143.2004.00618.x","article-title":"A prospective randomized study for the treatment of bone loss with vitamin D during kidney transplantation in children and adolescents","volume":"4","author":"El-Husseini","year":"2004","journal-title":"American Journal of Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD008327.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/s00467-006-0403-0","article-title":"Effects of deflazacort vs. methylprednisone: a randomized study in kidney transplant patients","volume":"22","author":"Ferraris","year":"2007","journal-title":"Pediatric Nephrology"},{"issue":"7","key":"10.1002\/14651858.CD008327.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1007\/s004670000337","article-title":"Effect of deflazacort versus methylprednisone on growth, body composition, lipid profile, and bone mass after renal transplantation. The Deflazacort Study Group","volume":"14","author":"Ferraris","year":"2000","journal-title":"Pediatric Nephrology"},{"issue":"Oct","key":"10.1002\/14651858.CD008327.pub2-BIB0095|cit95","first-page":"142A","article-title":"Pamidronate therapy for preventing steroid-induced bone loss in children receiving corticosteroid therapy [abstract no: F-PO346]","volume":"15","author":"Cho","year":"2004","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3-4","key":"10.1002\/14651858.CD008327.pub2-BIB0096|cit96","first-page":"c81","article-title":"Pamidronate therapy for preventing steroid-induced osteoporosis in children with nephropathy","volume":"102","author":"Kim","year":"2006","journal-title":"Nephron"},{"issue":"5","key":"10.1002\/14651858.CD008327.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/ki.1976.125","article-title":"Effects of 25- hydroxycholecalciferol on bone lesions of children with terminal renal failure","volume":"10","author":"Witmer","year":"1976","journal-title":"Kidney International"},{"issue":"1","key":"10.1002\/14651858.CD008327.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/089686080602600112","article-title":"Serum markers of low-turnover bone disease in Mexican children with chronic kidney disease undergoing dialysis","volume":"26","author":"Avila-Diaz","year":"2006","journal-title":"Peritoneal Dialysis International"},{"issue":"4","key":"10.1002\/14651858.CD008327.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00467-010-1745-1","article-title":"Bone assessment in children with chronic kidney disease: data from two new bone imaging techniques in a single-center pilot study","volume":"26","author":"Bacchetta","year":"2011","journal-title":"Pediatric Nephrology"},{"issue":"10","key":"10.1002\/14651858.CD008327.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.2215\/CJN.01330210","article-title":"Value of the new bone classification system in pediatric renal osteodystrophy","volume":"5","author":"Bakkaloglu","year":"2010","journal-title":"Clinical Journal of The American Society of Nephrology: CJASN"},{"issue":"8","key":"10.1002\/14651858.CD008327.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.2215\/CJN.05990710","article-title":"Cardiac geometry in children receiving chronic peritoneal dialysis: findings from the International Pediatric Peritoneal Dialysis Network (IPPN) registry","volume":"6","author":"Bakkaloglu","year":"2011","journal-title":"Clinical Journal of The American Society of Nephrology: CJASN"},{"issue":"7","key":"10.1002\/14651858.CD008327.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00467-005-1884-y","article-title":"Hyperphosphatemia in children receiving peritoneal dialysis--an educational program","volume":"20","author":"Blaszak","year":"2005","journal-title":"Pediatric Nephrology"},{"issue":"12","key":"10.1002\/14651858.CD008327.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/ki.2010.316","article-title":"The bone and mineral disorder of children undergoing chronic peritoneal dialysis","volume":"78","author":"Borzych","year":"2010","journal-title":"Kidney International"},{"issue":"20","key":"10.1002\/14651858.CD008327.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"New England Journal of Medicine"},{"issue":"7414","key":"10.1002\/14651858.CD008327.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD008327.pub2-BIB0106|cit106","unstructured":"Higgins JP Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"6","key":"10.1002\/14651858.CD008327.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/ki.1982.107","article-title":"Quantitative bone histology in children with chronic renal failure","volume":"21","author":"Hodson","year":"1982","journal-title":"Kidney International"},{"issue":"2","key":"10.1002\/14651858.CD008327.pub2-BIB0108|cit108","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003264.pub3","article-title":"Growth hormone for children with chronic kidney disease","author":"Hodson","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD008327.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2215\/CJN.03940510","article-title":"Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials","volume":"6","author":"Kandula","year":"2011","journal-title":"Clinical Journal of The American Society of Nephrology: CJASN"},{"key":"10.1002\/14651858.CD008327.pub2-BIB0110|cit110","unstructured":"National Kidney Foundation KDOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Children With Chronic Kidney Disease www2.kidney.org\/professionals\/KDOQI\/guidelines_pedbone\/"},{"issue":"3 Suppl 2","key":"10.1002\/14651858.CD008327.pub2-BIB0111|cit111","first-page":"S1","article-title":"KDOQI Clinical Practice Guideline for Nutrition in Children with CKD: 2008 Update","volume":"53","author":"KDOQI Work Group","year":"2009","journal-title":"American Journal of Kidney Diseases"},{"issue":"2","key":"10.1002\/14651858.CD008327.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00467-005-2082-7","article-title":"Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines","volume":"21","author":"Klaus","year":"2006","journal-title":"Pediatric Nephrology"},{"issue":"11","key":"10.1002\/14651858.CD008327.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney International"},{"issue":"2","key":"10.1002\/14651858.CD008327.pub2-BIB0114|cit114","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006023.pub2","article-title":"Phosphate binders for preventing and treating bone disease in chronic kidney disease patients","author":"Navaneethan","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008327.pub2-BIB0115|cit115","unstructured":"NCT01277510 A randomized, double-blind, placebo controlled study to assess the efficacy and safety of cinacalcet HCl in pediatric subjects with chronic kidney disease and secondary hyperparathyroidism receiving dialysis clinicaltrials.gov\/ct2\/show\/NCT01277510"},{"issue":"4","key":"10.1002\/14651858.CD008327.pub2-BIB0116|cit116","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008175","article-title":"Vitamin D compounds for people with chronic kidney disease not requiring dialysis","author":"Palmer","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD008327.pub2-BIB0117|cit117","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005633.pub2","article-title":"Vitamin D compounds for people with chronic kidney disease requiring dialysis","author":"Palmer","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD008327.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11154-007-9071-z","article-title":"Mineral metabolism and bone abnormalities in children with chronic renal failure","volume":"9","author":"Sanchez","year":"2008","journal-title":"Reviews in Endocrine & Metabolic Disorders"},{"issue":"5","key":"10.1002\/14651858.CD008327.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"8","key":"10.1002\/14651858.CD008327.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s00467-003-1158-5","article-title":"Chronic renal insufficiency in children: the 2001 Annual Report of the NAPRTCS","volume":"18","author":"Seikaly","year":"2003","journal-title":"Pediatric Nephrology"},{"issue":"10","key":"10.1002\/14651858.CD008327.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1093\/ndt\/gfm421","article-title":"Systematic review of the clinical efficacy and safety of sevelamer in dialysis patients","volume":"22","author":"Tonelli","year":"2007","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD008327.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2215\/CJN.05940611","article-title":"Early skeletal and biochemical alterations in pediatric chronic kidney disease","volume":"7","author":"Wesseling-Perry","year":"2012","journal-title":"Clinical Journal of The American Society of Nephrology: CJASN"},{"issue":"4","key":"10.1002\/14651858.CD008327.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00467-012-2324-4","article-title":"Bone disease in pediatric chronic kidney disease","volume":"28","author":"Wesseling-Perry","year":"2013","journal-title":"Pediatric Nephrology"},{"issue":"7644","key":"10.1002\/14651858.CD008327.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD008327.pub2-BIB0125|cit125","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008327","article-title":"Interventions for bone disease in children with chronic kidney disease","author":"Geary","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD008327.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T16:06:39Z","timestamp":1641398799000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD008327.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Kidney and Transplant Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,11,12]]},"references-count":125,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008327.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,12]]}}}